Strides Pharma Science schedules Mumbai investor meet for Q4FY26
Strides Pharma Science Limited announced a Non-Deal Road Show in Mumbai on June 12, 2026, hosted by DAM Capital. The in-person meeting will review Q4FY26 financial performance based on the earnings presentation uploaded on May 18, 2026.

*this image is generated using AI for illustrative purposes only.
Strides Pharma Science Limited will host a Non-Deal Road Show in Mumbai on June 12, 2026, to discuss its financial performance for the quarter ended March 31, 2026. Hosted by DAM Capital, this in-person session allows analysts and institutional investors to review the company's Q4FY26 results. The discussion will be based on the earnings presentation previously uploaded to the stock exchanges and company website on May 18, 2026.
The meeting is scheduled to commence at 10:00 hrs and will be conducted in a one-on-one format. This engagement provides a platform for management to present the business outlook and quarterly findings directly to stakeholders.
| Date & Time | Event Type | Mode/ Type of Meeting | Location |
|---|---|---|---|
| June 12, 2026 from 10:00 hrs onwards |
Non-Deal Road Show hosted by DAM Capital |
In-person (One-on-One) |
Mumbai, India |
Manjula Ramamurthy, Company Secretary & Compliance Officer, signed the disclosure regarding the meeting on June 8, 2026.
Historical Stock Returns for Strides Pharma Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.45% | +2.39% | -3.64% | +16.60% | +33.90% | +226.36% |
What specific growth drivers does Strides Pharma anticipate for the upcoming fiscal year following the Q4FY26 review?
How might the insights shared during this roadshow influence institutional investor sentiment towards the stock?
What are the expected market reactions to the company's business outlook presented during the one-on-one sessions?

































